Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with squamous cell carcinoma of the cervix (a specific type of cervical cancer affecting the outer cells of the cervix)
- People whose cancer tests positive for HER-2 (a protein found on some cancer cells that can affect how the cancer grows)
Who may not be able to join:
- People who have been diagnosed with cervical adenocarcinoma (a different type of cervical cancer that starts in the glandular cells of the cervix)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kun Song, Qilu Hospital of Shandong University
Phone: 86-0531-82169269
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
pathologic complete remission
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.